Sichuan Huiyu Pharmaceutical Co. Ltd. Class ASSE: 688553

Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Obtained by HY07121 Injection (Subcutaneous Injection)

· Issued by Sichuan Huiyu Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Obtained by HY07121 Injection (Subcutaneous Injection)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis